InvestorsHub Logo
Followers 3156
Posts 960705
Boards Moderated 203
Alias Born 09/04/2000

Re: Globewriter post# 232

Friday, 07/24/2020 11:47:55 PM

Friday, July 24, 2020 11:47:55 PM

Post# of 956
$MATN very good repore'

re;
A message relayed
“It seems that Steve King and Mateon have been getting some attention lately
and when is the PR scheduled for the Covid-19 Clinical trial
and CA4P just another surprise pending

- as Steve King was collaborating long ago with OXiGene
( name changed to Mateon )
and Oncotelic founders know well of Celgene / Abraxane ties :

this all leads quite the run up from .25 and instant $1+ stock. “

OT-101 is also being deployed as anti-COVID-19 agent.

The IND for COVID-19 has been submitted and we plan to initiate
the clinical trial as soon as possible.

http://investor.mateon.com/news-releases/news-release-details/fda-grants-pediatric-disease-designation-mateons-ca4p

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OTLC News